Concurrent Investment Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Concurrent Investment Advisors’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,557	Closed	-$733K	–	1479
2025 Q1	$733K	Buy	+5,557	New	+$693K	0.02%	634

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Concurrent Investment Advisors's ITCI Position: Q2 2025 in Review

Concurrent Investment Advisors sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 5,557 shares — an estimated $733K sold.

Concurrent Investment Advisors first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $733K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Concurrent Investment Advisors reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Concurrent Investment Advisors sold 5,557 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $733K.
Concurrent Investment Advisors first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
Concurrent Investment Advisors's Intra-Cellular Therapies Inc. position peaked at $733K in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Concurrent Investment Advisors's 13F filing for Q2 2025, filed 25 Jul 2025.